Erythropoietin-Stimulating Agent Hyporesponsiveness in Patients Living with Chronic Kidney Disease

• Κύριοι συγγραφείς: Henry H.L. Wu (Συγγραφέας), Rajkumar Chinnadurai (Συγγραφέας)
• Μορφή: Βιβλίο
• Έκδοση: Karger Publishers, 2022-01-01T00:00:00Z.
• Θέματα: article
• Διαθέσιμο Online: Connect to this object online.

Background: Erythropoietin-stimulating agent (ESA) hyporesponsiveness is commonly observed in patients with anemia secondary to chronic kidney disease (CKD). Because of its complexity, a global consensus on how we should define ESA hyporesponsiveness remains unavailable. The reported prevalence and...